Agena Suzuki, Akinori Hayashi, Satoshi Oda, Rei Fujishima, Naoya Shimizu, Kenta Matoba, Tomomi Taguchi, Takuya Toki, Takeshi Miyatsuka. Prolonged impacts of sodium glucose cotransporter-2 inhibitors on metabolic dysfunction-associated steatotic liver disease in type 2 diabetes: a retrospective analysis through magnetic resonance imaging. Endocrine journal. 2024. 71. 8. 767-775
Akihiko Suzuki, Tatsumi Moriya, Akinori Hayashi, Madoka Matsubara, Takeshi Miyatsuka. Arteriolar Hyalinosis Predicts the Onset of Both Macroalbuminuria and Impaired Renal Function in Patients with Type 2 Diabetes. Nephron. 2024. 148. 6. 390-398
Akinori Hayashi, Naoya Shimizu, Agena Suzuki, Rei Fujishima, Kenta Matoba, Ibuki Moriguchi, Naoyuki Kobayashi, Takeshi Miyatsuka. Novel clinical associations between time in range and microangiopathies in people with type 2 diabetes mellitus on hemodialysis. Journal of diabetes and its complications. 2023. 37. 5. 108470-108470
Akinori Hayashi, Kenta Matoba, Yasuhiro Ohata, Naoya Shimizu, Agena Suzuki, Satoe Fujii, Marie Sato, Koji Takano, Masayoshi Shichiri. Evaluation of the relationship between hemodialysis-related glycemic variability and hormonal profiles in patients with type 2 diabetes on hemodialysis: a pilot study. Renal Replacement Therapy. 2022
Naoya Shimizu, Akifumi Ogawa, Akinori Hayashi, Masayoshi Shichiri. Discordance in the reduction rate between glycated albumin and glycated hemoglobin levels in type 2 diabetes patients receiving SGLT2 inhibitors. Journal of diabetes and its complications. 2022. 36. 7. 108225-108225